Hoya, Eclipse in aesthetic laser pact:
This article was originally published in Clinica
Dental and aesthetic medical laser specialist Hoya ConBio has signed an exclusive three-year distribution agreement with Eclipse Medical for its MedLite C series and RevLite lasers. Eclipse will distribute the lasers in Texas, Louisiana, Arkansas and Oklahoma. Hoya (Freemont, California) claims that the MedLite C series and RevLite lasers, which use Q-switched Nd:YAG laser engineering, represent the next generation of laser engineering. This is because they treat patients via the delivery of energy with a "PhotoAcoustic" effect, as opposed to photothermal energy, which other devices use. These lasers are already used widely for tattoo removal, but also have potential uses for wrinkle reduction, acne scars, vascular and pigmented lesions and hair removal.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.